This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., Resistant hypertension is defined by the American Heart Association as elevated bloodpressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.
tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. If you have a history of diabetes, high bloodpressure, or tobacco use, you should talk to your doctor about being screened for PAD.
tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25
Stroke, Volume 56, Issue Suppl_1 , Page ATP266-ATP266, February 1, 2025. Effective bloodpressure (BP) management is crucial for reducing stroke and CVD risk, yet controlled hypertension remains suboptimal especially among minority populations. Background:Stroke is the 5thleading cause of death in the U.S. SD=15.8); 63.8%
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
Stroke, Volume 56, Issue 3 , Page 640-648, March 1, 2025. BACKGROUND:Stroke incidence is decreasing in older ages but increasing in young adults. The causal effect of body mass index on stroke was significantly stronger for EOS than for LOS (odds ratio, 1.26 versus 1.03;P=0.008).
tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across t he KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25
Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients.
Stroke, Volume 56, Issue Suppl_1 , Page AWP141-AWP141, February 1, 2025. In unadjusted analysis, factors significantly associated with troponin testing were a triage complaint of chest pain, older age, higher mean systolic BP, hypertension, diabetes, obesity, stroke or TIA, congestive heart failure, or coronary disease.
Stroke, Volume 56, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2025. Patients with increasing CT-CSVD scores were older (p<0.001), more likely to have hypertension (p<0.001), diabetes (p<0.001), coronary artery disease (p=0.044), and a higher baseline systolic bloodpressure (p=0.037).
Hypertension, Volume 82, Issue 1 , Page 136-148, January 1, 2025. Exposure to VOCs is associated with cardiovascular disease risk factors, including elevated bloodpressure in susceptible populations. had diabetes. had diabetes. BACKGROUND:Volatile organic compounds (VOCs) are ubiquitous environmental pollutants.
Stroke, Volume 56, Issue 1 , Page 95-104, January 1, 2025. Cerebral blood flow (CBF) was measured through 2-dimensional phase-contrast magnetic resonance imaging; the cerebrovascular resistance index (CVRi) was defined as the ratio of mean arterial bloodpressure to total CBF.
Stroke, Volume 56, Issue Suppl_1 , Page ADP21-ADP21, February 1, 2025. Vascular risk factors like hypertension, diabetes, and hyperlipidemia are highly heritable, and persons with higher polygenic predisposition are less likely to achieve risk factor control.
Stroke, Volume 56, Issue Suppl_1 , Page AWP235-AWP235, February 1, 2025. Introduction:Insurance status may serve as an indicator of social and financial barriers that impede access to quality care. Disparities in outcomes of patients with ischemic stroke have been associated with insurance coverage.
Stroke, Volume 56, Issue Suppl_1 , Page AWP234-AWP234, February 1, 2025. Introduction:Education, a key modifiable social determinant of health, plays a significant role in shaping outcomes related to ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page A102-A102, February 1, 2025. Background and Purpose:Chronic kidney disease (CKD) is associated with an increased risk of stroke and worse outcomes, yet it is often asymptomatic, with an estimated 90% of individuals unaware they have CKD until its later stages. female, 22.1%
Stroke, Volume 56, Issue Suppl_1 , Page ATMP20-ATMP20, February 1, 2025. Data collection included demographics, risk factors, bloodpressures (BPs), and other variables such as the National Institute of Health Stroke Score (NIHSS), presence and types of large vessel occlusion, and severity of the hemorrhage (symptomatic or asymptomatic).Results:The
Diabetes and Obesity Care Advancements New Technologies for Diabetes Management : The recent FDA approvals of various insulin delivery devices, including the Embecta patch pump for Type 2 diabetes , have expanded patient options. New developments in continuous glucose monitors (CGMs) have also been transformative.
42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S., SELECT Trial Results : Semaglutide 2.4
Lower levels of muscle mass are strongly linked to a shorter life and higher rates of major chronic diseases such as diabetes 2. The BloodPressure Secrets Masterclass. BloodPressure Secrets Masterclass. Most people are confused by high bloodpressure and what to do about it. Age and strength loss.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content